MASH

Gastroenterology·MeSH: Non-alcoholic Fatty Liver Disease

27 drugs in development·17 companies·4 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
Rezdiffra	MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Phase 3(6)

Drug	Company
100 mg resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
efruxifermin (EFX)	Akero Therapeutics, Inc. (AKRO)
hydronidone	GYRE THERAPEUTICS, INC. (GYRE)
Pegozafermin	89bio, Inc. (ETNB)
Resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
UBT251	UNITED THERAPEUTICS Corp (UTHR)

Phase 2(10)

Drug	Company
ALG-055009	Aligos Therapeutics, Inc. (ALGS)
aln-hsd	REGENERON PHARMACEUTICALS, INC. (REGN)
da-1241	MetaVia Inc. (MTVA)
efruxifermin	Akero Therapeutics, Inc. (AKRO)
ervogastat	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
fxr314	VivoSim Labs, INC. (VIVS)
GSK-4532990	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
hu6	Corvus Pharmaceuticals, Inc. (CRVS)
hu6	West Pharmaceutical Services Inc. (WST)
vanoglipel	MetaVia Inc. (MTVA)

Phase 1(5)

Drug	Company
aln-cideb	REGENERON PHARMACEUTICALS, INC. (REGN)
ARO-PNPLA3	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
denifanstat	Sagimet Biosciences Inc. (SGMT)
MGL-2086	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
tern-501	Terns Pharmaceuticals, Inc. (TERN)

Preclinical(3)

Drug	Company
CT-2401	Carisma Therapeutics Inc. (CARM)
f351	GYRE THERAPEUTICS, INC. (GYRE)
siRNA programs	MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Phase 1/Phase 2(2)

Drug	Company
opk-88006	OPKO HEALTH, INC. (OPK)
WVE-008	Wave Life Sciences Ltd. (WVE)

BioSniper tracks 27 drugs in development for MASH across 17 companies.

There are 4 clinical trials targeting MASH tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.